Revance Therapeutics, Inc.
Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease
Last updated:
Abstract:
A composition of botulinum toxin is claimed which can penetrate into the ocular surface inclusive of a penetration through a conjunctiva, cornea, and other structures. This composition allows for a maximal penetration of a topical preparation of botulinum toxin which serves to reduce the need for frequent allergy drops for the treatment of ocular surface disease and other conditions causing ocular surface inflammation or deep ocular inflammation. No puncture of the needle is necessary for the administration. Herein describes a novel composition using several principles based on composition, method of application, which enhances the effectiveness of the penetration.
Status:
Application
Type:
Utility
Filling date:
26 Feb 2018
Issue date:
16 Jul 2020